(HealthDay)—Compared with placebo, neither aspirin nor apixaban reduces the rate of major adverse cardiovascular or pulmonary outcomes for clinically stable outpatients with symptomatic COVID-19, according to a study published ...
Oct 18, 2021
0
16
Older adults without heart disease shouldn't take daily low-dose aspirin to prevent a first heart attack or stroke, an influential health guidelines group said in preliminary updated advice released Tuesday.
Oct 12, 2021
0
155
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) recommends low-dose aspirin for reducing the risk for preeclampsia among those at high risk. This recommendation forms the basis of the final recommendation statement ...
Sep 28, 2021
0
2
New research presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) taking place online (9-12 July) shows that aspirin can reduce the risk of serious cardiovascular events such ...
Jul 8, 2021
0
1
(HealthDay)—For patients undergoing percutaneous coronary intervention, ticagrelor monotherapy following three months of dual antiplatelet therapy significantly reduces clinically relevant bleeding compared with ticagrelor ...
Jul 7, 2021
0
5
Patients with a wide range of cancers who take aspirin as part of their treatment could help to reduce their risk of death by 20%, a major review of existing research has suggested.
Jul 2, 2021
0
174
(HealthDay)—Many older adults are still taking a daily baby aspirin to ward off first-time heart problems—despite guidelines that now discourage it, a new study finds.
Jun 22, 2021
0
12
The RECOVERY trial was established as a randomized clinical trial to test a range of potential treatments for patients hospitalized with COVID-19.
Jun 9, 2021
0
0
Clopidogrel outperformed aspirin in what is believed to be the first and largest randomized trial to compare the effectiveness of the two antiplatelet drugs as long-term maintenance therapy for patients who had no adverse ...
May 17, 2021
0
4
Rivaroxaban, in addition to low-dose aspirin, significantly reduced the occurrence of total severe events of the heart, limb or brain and issues related to other vascular complications in patients with symptomatic peripheral ...
May 17, 2021
0
3
